剂泰科技-P今日盘中大涨5.53%，引起了市场的广泛关注。
消息面上，剂泰科技宣布与肿瘤免疫细胞治疗企业沙砾生物正式签署全面技术合作战略协议，双方将围绕免疫靶向脂质纳米颗粒（LNP）递送技术展开合作，共同推进新一代体内免疫治疗产品的研发与转化，此举提振了市场对公司技术实力和未来增长前景的信心。
此次合作依托剂泰科技自研的全球首个AI纳米递送平台NanoForge，是其OpenCGT项目赋能合作伙伴的又一重要里程碑。截至目前，剂泰科技OpenCGT项目已与多家细胞与基因治疗（CGT）领域企业达成技术合作，累计合作总额已超过60亿元人民币，展现了其平台技术的商业吸引力和行业影响力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.